The Board is pleased to announce that in accordance with the terms of the Offer for Subscription dated 26 September 2013 (the "Offer"), 865,736 Ordinary Shares of 1 pence each were allotted on 15 January 2014 on an issue price based on an Net Asset Value of 102.20 pence per share.
Application has been made for the admission of the 865,736 Ordinary Shares to the Official List of the UK Listing Authority and to trading on London Stock Exchange plc's market for listed securities.
Total shares allotted to date under the Offer by the Company now total 4,529,552 Ordinary Shares. Following this allotment there are now 31,694,880 Ordinary Shares of 1p each in issue.
For further information please contact:
Gary Fraser, Foresight Group: 01732 471 800
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Foresight VCT PLC via Globenewswire
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.